An observational study in Lung Dysfunction and Inflammatory Response During Cardiac Surgery, sponsored by Massachusetts General Hospital. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-03-06.
Sponsored by Massachusetts General Hospital · Observational
The hypotheses of this study are that:
In this project, we will test the hypothesis that cys-leukotrienes are released and correlated with the impairment of the lung function after cardiac surgery in patients with COPD. If such hypothesis is substantiated in the study, it would allow us to propose the use of leukotriene inhibitors in the peri-operative period to improve pulmonary function and to decrease complications after cardiac surgery in COPD patients.
2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.
This study's enrollment of 20 is below the median of 150 across 639 observational studies indexed under Lung Diseases, Obstructive.
Browse Lung Diseases, Obstructive studies →Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult patients schedules to undergo cardiac surgery with use of CPB.
Exclusion Criteria:
Patients with and without chronic obstructive pulmonary disease diagnosed before scheduling for cardiac surgery.
Patients with and without chronic obstructive pulmonary disease diagnosed before scheduling for cardiac surgery.
urine cysteinyl leukotriene
Time frame: intra-operative
No study locations are listed for this record.
This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital